The Ademi Firm is investigating Allakos (Nasdaq: ALLK) for possible breaches of fiduciary duty and other violations of law in its transaction with Concentra.
In the tender offer transaction, shareholders of Allakos will receive $0.33 in cash per each share of Allakos common stock. Allakos insiders holding approximately 8.07% of Allakos shares have signed agreements to tender their shares in the transaction. Allakos insiders will receive substantial benefits as part of change of control arrangements.
The transaction agreement unreasonably limits competing transactions for Allakos by imposing a significant penalty if Allakos accepts a competing bid. We are investigating the conduct of the Allakos board of directors, and whether they are fulfilling their fiduciary duties to all shareholders.